Genelux (GNLX) Revenue (2022 - 2024)
Genelux's (GNLX) quarterly Revenue came in at $8000.0 in Q1 2024, down 95.29% year-on-year from $170000.0 in Q2 2023, and down 95.29% quarter-over-quarter from $170000.0 in Q1 2023.
Genelux (GNLX) Revenue (2022 - 2024) Analysis & Trends
Genelux's Revenue history runs 3 years deep, the most recent figure standing at $8000.0 for Q1 2024.
- On a quarterly basis, Revenue fell 95.29% year-over-year to $8000.0 in Q1 2024; TTM through Dec 2024 was $8000.0, a 95.29% decrease from a year earlier, with the FY2025 full-year figure at $8000.0, changed 0.0% from the prior year.
- Revenue retreated to $8000.0 in Q1 2024 per GNLX's latest filing, from $170000.0 in the prior quarter.
- Across five years, Revenue topped out at $11.0 million in Q3 2022 and bottomed at -$10.8 million in Q4 2022.
- The 3-year median for Revenue is $89000.0 (2023), against an average of $87000.0.
- Biggest YoY gain for Revenue was 95.29% in 2024; the steepest drop was 95.29% in 2024.
- Year by year, Revenue stood at -$10.8 million in 2022, then surged by 101.57% to $170000.0 in 2023, then plunged by 95.29% to $8000.0 in 2024.
- Per Business Quant, the three latest GNLX Revenue figures stand at $8000.0 (Q1 2024), $170000.0 (Q1 2023), and -$10.8 million (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Genelux | 130.69 Mn | 130.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 8,000.00 |
| Mar 31, 2023 | 170,000.00 |
| Dec 31, 2022 | -10.83 Mn |
| Sep 30, 2022 | 11.00 Mn |